2015;18: 252 6. S3.3-20. Duffels MGJ, Engelfriet PM, Berger RMF, et al. Pulmonary arterial hy- pertension in congenital heart disease: an epidemiologic perspective from a Dutch registry. Int J Cardiol. 2007;120:198 204. S3.3-21. Lowe BS, Therrien J, Ionescu-Ittu R, et al. Diagnosis of pulmonary hypertension in the congenital heart disease adult population impact on outcomes. J Am Coll Cardiol. 2011;58:538 46. S3.3-22. Van De Bruaene A, Delcroix M, Pasquet A, et al. The importance of pulmonary artery pressures on late atrial arrhythmia in trans- catheter and surgically closed ASD type secundum. Int J Cardiol. 2011;152:192 5. S3.3-23. Barst RJ, Ivy DD, Foreman AJ, et al. Four- and seven-year outcomes of patients with congenital heart disease-associated pulmonary arterial hypertension (from the REVEAL Registry). Am J Cardiol. 2014;113:147 55. S3.3-24. D'Alto M, Romeo E, Argiento P, et al. Therapy for pulmonary arterial hypertension due to congenital heart disease and Down s syndrome. Int J Cardiol. 2013;164:323 6. S3.3-25. Engelfriet PM, Duffels MGJ, M ller T, et al. Pulmonary arterial hy- pertension in adults born with a heart septal defect: the Euro Heart Survey on adult congenital heart disease. Heart. 2007;93: 682 7. S3.3-26. Manes A, Palazzini M, Leci E, et al. Current era survival of patients with pulmonary arterial hypertension associated with congenital heart disease: a comparison between clinical subgroups. Eur Heart J. 2014;35:716 24. S3.3-27. O Donnell C, Ruygrok PN, Whyte K, et al. Progressive pulmonary hypertension post atrial septal defect device closure early symp- tomatic improvement may not predict outcome. Heart Lung Circ. 2010;19:713 6. S3.3-28. Van De Bruaene A, Moons P, Belmans A, et al. Predictive model for late atrial arrhythmia after closure of an atrial septal defect. Int J Cardiol. 2013;164:318 22. S3.3-29. D Alto M, Romeo E, Argiento P, et al. 